None of the steroid medication linked to a national fungal meningitis outbreak was sent to Utah, but state health officials are warning residents who have received recent epidural or joint steroid injections to watch for symptoms.
Idaho clinics are among facilities that received vials from three lots recalled by the New England Compounding Center in Framingham, Mass., health officials note. Pain Specialists of Idaho in Idaho Falls and Walter Knox Memorial Hospital in Emmett received recalled medication, according to the Centers for Disease Control and Prevention (CDC).
"The possibility of exposure does exist for any Utah residents who received an epidural injection treatment within the past couple of months at a clinic/facility in Idaho named in the...list," the Utah Department of Health said in a statement.
This week, out of "an abundance of caution," the company decided to expand its recall to all products produced at and distributed from its Framingham facility, the department said.
Some Utah clinics and facilities received epidural medications and others included in that expanded recall but none of those products have been linked to the outbreak, it stresses.
Symptoms seen in victims of the outbreak include headache, neck pain or stiffness, fever, nausea, vomiting, and in some cases, weakness or numbness and sensitivity to light. Most have begun experiencing symptoms one to four weeks after their epidural injection.
As of Wednesday, 137 cases had been reported and 12 deaths had been associated with the outbreak. All of the cases have occurred in patients who received an epidural injection using methylprednisolone acetate from the three recalled lots.
The list of facilities that received medication from those lots can be found on the CDC's website.
While a Nevada surgery center received recalled vials, none were administered to patients. All cases have occurred in these 10 states: Florida, Indiana, Maryland, Michigan, Minnesota, New Jersey, North Carolina, Ohio, Tennessee, and Virginia.